Literature DB >> 17242227

Low-grade myxofibrosarcoma: CT and MRI patterns in recurrent disease.

Brendan Waters1, David M Panicek, Robert A Lefkowitz, Cristina R Antonescu, John H Healey, Edward A Athanasian, Murray F Brennan.   

Abstract

OBJECTIVE: Low-grade myxofibrosarcoma often relentlessly recurs after surgical resection, with an unusual infiltrative growth pattern and sometimes without a discrete tumor nodule at pathologic examination. This study was undertaken to determine and show patterns of recurrent low-grade myxofibrosarcoma at CT and MRI.
CONCLUSION: Unlike in most other histologic types of low-grade soft-tissue sarcoma, recurrent low-grade myxofibrosarcoma often is infiltrative; shows a tapering, tail-like margin and superficial spreading configuration; and metastasizes to various distant sites, including lungs, pleura, bone, adrenal gland, soft tissue, and mesentery. Knowledge of these unusual characteristics is important in assessing the presence and extent of recurrent low-grade myxofibrosarcoma before surgical reexcision.

Entities:  

Mesh:

Year:  2007        PMID: 17242227     DOI: 10.2214/AJR.05.1130

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  25 in total

1.  An analysis of factors related to the tail-like pattern of myxofibrosarcoma seen on MRI.

Authors:  Kazutaka Kikuta; Daisuke Kubota; Akihiko Yoshida; Hideo Morioka; Yoshiaki Toyama; Hirokazu Chuuman; Akira Kawai
Journal:  Skeletal Radiol       Date:  2014-08-30       Impact factor: 2.199

Review 2.  Giant myxofibrosarcoma of the orbit: a rare case and a review of the literature.

Authors:  Rachna Meel; Gautam Lokdarshi; Seema Kashyap; Sanjay Sharma
Journal:  BMJ Case Rep       Date:  2016-06-13

Review 3.  Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives.

Authors:  Brigitte C Widemann; Antoine Italiano
Journal:  J Clin Oncol       Date:  2017-12-08       Impact factor: 44.544

Review 4.  Musculoskeletal tumours and tumour-like conditions: common and avoidable pitfalls at imaging in patients with known or suspected cancer: Part B: malignant mimics of benign tumours.

Authors:  Gary Ulaner; Sinchun Hwang; Jonathan Landa; Robert A Lefkowitz; David M Panicek
Journal:  Int Orthop       Date:  2013-02-17       Impact factor: 3.075

5.  The enigma of myxofibrosarcoma of the extremity.

Authors:  Robert W Mutter; Samuel Singer; Zhigang Zhang; Murray F Brennan; Kaled M Alektiar
Journal:  Cancer       Date:  2011-06-29       Impact factor: 6.860

6.  Prognostic factors and outcomes of patients with myxofibrosarcoma.

Authors:  G Petur Nielsen; John T Mullen; Nicole J Look Hong; Francis J Hornicek; Kevin A Raskin; Sam S Yoon; Jackie Szymonifka; Beow Yeap; Yen-Lin Chen; Thomas F DeLaney
Journal:  Ann Surg Oncol       Date:  2012-08-14       Impact factor: 5.344

Review 7.  Local recurrence of soft-tissue sarcoma: issues in imaging surveillance strategy.

Authors:  Nisreen S Ezuddin; Juan Pretell-Mazzini; Raphael L Yechieli; Darcy A Kerr; Breelyn A Wilky; Ty K Subhawong
Journal:  Skeletal Radiol       Date:  2018-05-21       Impact factor: 2.199

8.  Myxofibrosarcoma: prevalence and diagnostic value of the "tail sign" on magnetic resonance imaging.

Authors:  Robert A Lefkowitz; Jonathan Landa; Sinchun Hwang; Emily C Zabor; Chaya S Moskowitz; Narasimhan P Agaram; David M Panicek
Journal:  Skeletal Radiol       Date:  2013-01-15       Impact factor: 2.199

9.  Myxofibrosarcoma arising in the maxillary sinus: a case report with a review of the ultrastructural findings and differential diagnoses.

Authors:  Ernst J G Norval; Erich J Raubenheimer
Journal:  J Maxillofac Oral Surg       Date:  2011-07-27

10.  MRI and histological evaluation of the infiltrative growth pattern of myxofibrosarcoma.

Authors:  Mitsunori Kaya; Takuro Wada; Satoshi Nagoya; Mikito Sasaki; Tadaki Matsumura; Takehiko Yamaguchi; Tadashi Hasegawa; Toshihiko Yamashita
Journal:  Skeletal Radiol       Date:  2008-07-16       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.